The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 10, 2017
Filed:
Apr. 15, 2015
Applicant:
Dr. Reddy's Laboratories Ltd., Hyderabad, IN;
Inventors:
Anima Baruah, Hyderabad, IN;
Dibyendu De, Suwanee, GA (US);
Ish Kumar Khanna, Alpharetta, GA (US);
Sivaram Pillarisetti, Norcross, GA (US);
Santanu Maitra, Hyderabad, IN;
Christopher W. Alexander, Atlanta, GA (US);
Jennepalli Sreenu, Hyderabad, IN;
Indu Dager, Ghaziabad, IN;
Shanavas Alikunju, Secunderabad, IN;
Assignee:
DR. REDDY'S LABORATORIES LTD., Hyderabad, IN;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 31/437 (2006.01); A61K 31/438 (2006.01); A61K 31/496 (2006.01); C07D 239/78 (2006.01); C07D 213/73 (2006.01); C07D 221/04 (2006.01); C07D 241/20 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 498/04 (2006.01); C07D 213/74 (2006.01); C07D 215/38 (2006.01); C07D 213/38 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 31/437 (2013.01); A61K 31/438 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); C07D 213/73 (2013.01); C07D 213/74 (2013.01); C07D 215/38 (2013.01); C07D 221/04 (2013.01); C07D 239/78 (2013.01); C07D 241/20 (2013.01); C07D 401/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.